RT @rbryanbell: Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1 | Nice…
RT @NatureComms: Study reveals molecular similarities between GBM and melanoma and unique patterns of immunosuppression in GBM indicating p…
@rincewind_LU @NgAlphonsus @labheath
RT @StemmGlobal: Work from the @isbsci describes a new method to look at tumours using machine learning-based image analysis for multiplexe…
Work from the @isbsci describes a new method to look at tumours using machine learning-based image analysis for multiplexed spatial profiling of proteins. The method can be used increase the effectiveness of immunotherapies. https://t.co/gvSgqw5sjv #oncol
RT @NCIPhySci: Investigators @isbsci/ @Caltech #PSON developed a framework that uses spatial protein profiling, image analysis, and #comput…
RT @NCIPhySci: Investigators @isbsci/ @Caltech #PSON developed a framework that uses spatial protein profiling, image analysis, and #comput…
Investigators @isbsci/ @Caltech #PSON developed a framework that uses spatial protein profiling, image analysis, and #computationalmodels to investigate the factors within the tumor microenvironment that influence treatment response @NatureComms https://t.
A new method of cell proximity analysis may unlock the complexity of treating patients with Glioblastoma multiforme (GBM). 🗝️👉 Check out this @NatureComms paper using our IO360+GeoMx profiling https://t.co/68CcxFyU6E #CancerMicroEnvironment #Immunology #
https://t.co/flNP4nbSJY Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1
RT @NatureComms: Study reveals molecular similarities between GBM and melanoma and unique patterns of immunosuppression in GBM indicating p…
RT @NatureComms: Study reveals molecular similarities between GBM and melanoma and unique patterns of immunosuppression in GBM indicating p…
'This work reveals similarities shared between glioblastoma & melanoma, immunosuppressive factors that are unique to the glioblastoma microenvironment, and potential co-targets for enhancing the efficacy of neoadjuvant immune checkpoint blockade' https
RT @NatureComms: Study reveals molecular similarities between GBM and melanoma and unique patterns of immunosuppression in GBM indicating p…
Study reveals molecular similarities between GBM and melanoma and unique patterns of immunosuppression in GBM indicating potential co-targets for neoadjuvant ICB. #CancerResearch @LabHeath @rincewind_LU @isbsci @NgAlphonsus https://t.co/vWLeqpObUR http
Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1 https://t.co/MZulG22CfS https://t.co/yB0WwTPit0
Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1 https://t.co/aHzto8DFgc
Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1 https://t.co/yxbcq84J05
New article: Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1 https://t.co/tCMu18CLnN #melanoma #oncology https://t.co/QBgJ8ms6dt
RT @rbryanbell: Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1 | Nice…
Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1 | Nice work from @LabHeath et al @isbsci @JenWargoMD @MDAndersonNews @UCLA @providence https://t.co/VHB95KUiuy
Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1 | Nature Communications https://t.co/VWmDYqU3xM